Connection

Alexandre Mebazaa to Human Experimentation

Back to Details
This is a "connection" page, showing publications Alexandre Mebazaa has written about Human Experimentation.
Alexandre Mebazaa
Connection Strength
0.038
Human Experimentation
  1. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol. 2018 09; 84(9):2129-2141.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.